학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 51건 | 목록 1~20
Book
Political Communication, Culture, and Society ISBN: 9781003391692
Academic Journal
Le Du F; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Medical Oncology, Eugène Marquis Cancer Center, Rennes, France.; Fujii T; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Kida K; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Davis DW; ApoCell, Inc., Houston, Texas, United States of America.; Park M; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Liu DD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Wu W; ApoCell, Inc., Houston, Texas, United States of America.; Chavez-MacGregor M; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Barcenas CH; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Valero V; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Tripathy D; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Reuben JM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Ueno NT; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Lim B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Murthy RK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee J; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jackson SA; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Methodist Hospital, Houston, TX, USA.; Iwase T; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davis DW; ApoCell, Houston, TX, USA.; Willey JS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wu J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shen Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Alvarez R; Southeastern Regional Medical Center, Newnan, GA, USA.; Ibrahim NK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Brewster AM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Brown PH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Giordano SH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moulder SL; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Booser DJ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moscow JA; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD, USA.; Piekarz R; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD, USA.; Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. nueno@mdanderson.org.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. nueno@mdanderson.org.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Academic Journal
Rugo HS; University of California, San Francisco, San Francisco, California.; Cortes J; Ramon y Cajal University Hospital, Madrid, and Vall D'Hebron Institute of Oncology, Barcelona, Spain.; Awada A; Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.; O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas.; Twelves C; University of Leeds and Leeds Teaching Hospital Trust, Leeds, United Kingdom.; Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Hannah A; Nektar Therapeutics, San Francisco, California.; Lu L; Nektar Therapeutics, San Francisco, California.; Sy S; Nektar Therapeutics, San Francisco, California.; Caygill K; Nektar Therapeutics, San Francisco, California.; Zajchowski DA; Consultant, San Francisco, California.; Davis DW; ApoCell, Houston, Texas.; Tagliaferri M; Nektar Therapeutics, San Francisco, California.; Hoch U; Nektar Therapeutics, San Francisco, California. uhoch@nektar.com.; Perez EA; Mayo Clinic, Jacksonville, Florida.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
O'Shannessy DJ; Senior Director, Translational Medicine and Diagnostics, Morphotek, Inc., Exton, PA, USA.; Davis DW; President and CEO, ApoCell, Inc., Houston, TX, USA.; Anderes K; Vice President of Scientific Affairs, ApoCell, Inc., Houston, TX, USA.; Somers EB; Director Diagnostics, Translational Medicine and Diagnostics, Morphotek, Inc., Exton, PA, USA.
Publisher: SAGE Publications Country of Publication: United States NLM ID: 101288638 Publication Model: eCollection Cited Medium: Print ISSN: 1177-2719 (Print) Linking ISSN: 11772719 NLM ISO Abbreviation: Biomark Insights Subsets: PubMed not MEDLINE
Academic Journal
Gupta V; ApoCell, Inc., Houston, Texas 77054, USA.; Jafferji IGarza MMelnikova VOHasegawa DKPethig RDavis DW
Publisher: American Institute of Physics Country of Publication: United States NLM ID: 101293825 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1932-1058 (Electronic) Linking ISSN: 19321058 NLM ISO Abbreviation: Biomicrofluidics Subsets: PubMed not MEDLINE
Academic Journal
de Souza JA; Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medical Center, Chicago, Illinois, USA.; Davis DWZhang YKhattri ASeiwert TYAktolga SWong SJKozloff MFNattam SLingen MWKunnavakkam RStenson KMBlair EABozeman JDancey JEVokes EECohen EE
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Tellez CS; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.; Davis DWPrieto VGGershenwald JEJohnson MMMcCarty MFBar-Eli M
Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE
Academic Journal
Berger AJ; Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, USA.; Davis DWTellez CPrieto VGGershenwald JEJohnson MMRimm DLBar-Eli M
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Mohamedali KA; Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.; Kedar DSweeney PKamat ADavis DWEve BYHuang SThorpe PEDinney CPRosenblum MG
Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print Cited Medium: Print ISSN: 1522-8002 (Print) Linking ISSN: 14765586 NLM ISO Abbreviation: Neoplasia Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Davis, Darren W
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어